Search research articles
Contact Us
Filters
Showing results (241-250 of 280) with videos related to
Page
of 28
Sort By:
BMC Medicine
|
March 17, 2023
Safety, tolerability, pharmacokinetics, and antiviral activity of the novel core protein allosteric modulator ZM-H1505R (Canocapavir) in chronic hepatitis B patients: a randomized multiple-dose escalation trial
Haiyan Jia, Jiajia Mai, Min Wu, et al.
Gastroenterology
|
November 26, 2008
2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B
Yun-Fan Liaw, Edward Gane, Nancy Leung, et al.
Hepatology (Baltimore, Md.)
|
August 16, 2021
Efficacy and safety of a nanoparticle therapeutic vaccine in patients with chronic hepatitis B: A randomized clinical trial
Lai Wei, Tingting Zhao, Ji Zhang, et al.
Emerging Microbes & Infections
|
May 28, 2021
A new nairo-like virus associated with human febrile illness in China
Yan-Chun Wang, Zhengkai Wei, Xiaolong Lv, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
July 30, 2020
Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks
Xiaomei Wang, Zhongfeng Wang, Xiumei Chi, et al.
Alimentary Pharmacology & Therapeutics
|
September 29, 2021
Randomised clinical trial: 48 weeks of treatment with tenofovir amibufenamide versus tenofovir disoproxil fumarate for patients with chronic hepatitis B
Zhihong Liu, Qinglong Jin, Yuexin Zhang, et al.
Alimentary Pharmacology & Therapeutics
|
June 22, 2021
Association of central obesity with hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy
Rong Fan, Junqi Niu, Hong Ma, et al.
Cell Metabolism
|
October 23, 2025
The enedioic acid analog 326E alleviates metabolic dysfunction-associated steatohepatitis via dual targeting at ACLY and PPARα
Zhifu Xie, Long Cheng, Yue Hu, et al.
Hepatology International
|
May 29, 2026
Tolvaptan for hyponatremia in patients with cirrhosis: a post hoc subgroup analysis of a multicenter, randomized, double-blind, placebo-controlled trial
Yu Wang, Huifen Wang, Jun Cheng, et al.
Hepatology International
|
April 13, 2019
Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results
Xieer Liang, Zhiliang Gao, Qing Xie, et al.
Page
of 28
Search research articles
Search
Showing results (241-250 of 280) with videos related to
Sort By:
Page
of 28
BMC Medicine
|
March 17, 2023
Safety, tolerability, pharmacokinetics, and antiviral activity of the novel core protein allosteric modulator ZM-H1505R (Canocapavir) in chronic hepatitis B patients: a randomized multiple-dose escalation trial
Haiyan Jia, Jiajia Mai, Min Wu, et al.
Gastroenterology
|
November 26, 2008
2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B
Yun-Fan Liaw, Edward Gane, Nancy Leung, et al.
Hepatology (Baltimore, Md.)
|
August 16, 2021
Efficacy and safety of a nanoparticle therapeutic vaccine in patients with chronic hepatitis B: A randomized clinical trial
Lai Wei, Tingting Zhao, Ji Zhang, et al.
Emerging Microbes & Infections
|
May 28, 2021
A new nairo-like virus associated with human febrile illness in China
Yan-Chun Wang, Zhengkai Wei, Xiaolong Lv, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
July 30, 2020
Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks
Xiaomei Wang, Zhongfeng Wang, Xiumei Chi, et al.
Alimentary Pharmacology & Therapeutics
|
September 29, 2021
Randomised clinical trial: 48 weeks of treatment with tenofovir amibufenamide versus tenofovir disoproxil fumarate for patients with chronic hepatitis B
Zhihong Liu, Qinglong Jin, Yuexin Zhang, et al.
Alimentary Pharmacology & Therapeutics
|
June 22, 2021
Association of central obesity with hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy
Rong Fan, Junqi Niu, Hong Ma, et al.
Cell Metabolism
|
October 23, 2025
The enedioic acid analog 326E alleviates metabolic dysfunction-associated steatohepatitis via dual targeting at ACLY and PPARα
Zhifu Xie, Long Cheng, Yue Hu, et al.
Hepatology International
|
May 29, 2026
Tolvaptan for hyponatremia in patients with cirrhosis: a post hoc subgroup analysis of a multicenter, randomized, double-blind, placebo-controlled trial
Yu Wang, Huifen Wang, Jun Cheng, et al.
Hepatology International
|
April 13, 2019
Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results
Xieer Liang, Zhiliang Gao, Qing Xie, et al.
Page
of 28